TAMRO EESTI OÜ

Osaühing · 10173188 · Registrisse kantud

Download PDFDownload CSV

Activity

TAMRO EESTI OÜ is a large enterprise in trade, with declared activity “Ravimite ja muude apteegikaupade hulgimüük” (EMTAK 46461). Annual revenue stands at 221.29 M € with 180 employees, ranks #22 of 27,603 in trade.

Public procurement

Public-sector contracts this company has won via the Estonian Public Procurement Register.

Contract value
334.50 M €
Contracts
878
Buyers
24
Most recent
2026-03-26
BuyerValueYear
Tervishoiuteenuste osutamisel kasutatavate ravimite ostmine
Ravimid
sihtasutus Tartu Ülikooli Kliinikum20.20 M €2025
Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla18.00 M €2024
Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla17.00 M €2025
Vereplasma töötlemine, vereplasmast toodetud ravimi ostmine, hüübimisfaktorid
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla15.00 M €2025
Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla10.00 M €2024
Kontrastained
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla7.00 M €2024
Monoklonaalsed antikehad, immuunosupressandid, teised astmavastased ained süsteemseks kasutamiseks, teised dermatoloogilised preparaadid 2
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla7.00 M €2024
Immunosupressantide ja immunostimulaatorite ostmine
Antineoplastilised ja immuunmoduleerivad ained
Aktsiaselts Lääne-Tallinna Keskhaigla6.89 M €2024
Antiretroviirusravimite ostmine
Ravimid
Tervisekassa6.64 M €2025
Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained
Ravimid
sihtasutus Põhja-Eesti Regionaalhaigla6.10 M €2025

Overview (2024)

Revenue
221.29 M €
▲ 106124%YoY
▲ 1000+×above industry median
Profit
3.71 M €
▲ 88595%YoY
Profit margin
1.7%
Employees
180
▲ 2.9%YoY
Revenue per employee
1.23 M €
Cost per employee
52.4 k €
Equity
24.09 M €

Growth

Revenue
221.29 M €
▲ 106124%
1y
▲ 9.6%
3y CAGR
5y CAGR
Profit
3.71 M €
▲ 88595%
1y
▲ 2.5%
3y CAGR
5y CAGR
Employees
180
▲ 2.9%
1y
▲ 8.5%
3y CAGR
5y CAGR

Trends

Revenue trend
221.29 M €
Profit trend
3.71 M €
Headcount trend
180

Revenue to profit

221.3 M €Revenue−9.4 M €Labor cost−208.2 M €Other costs3.7 M €Profit

Capital structure

  • Equity28%
  • Liabilities72%

Financials

YearRevenueGrowthProfitMarginEmployeesRevenue per employeeEquity
2024221.29 M €3.71 M €2%1801.23 M €24.09 M €
2024
2023208.3 k €4.2 k €2%1751.2 k €24.4 k €
2023
2022196.15 M €4.65 M €2%1671.17 M €24.20 M €
2022
2021167.94 M €3.45 M €2%1411.19 M €23.55 M €
2021
2020
2019

Similar companies

Same industry, comparable revenue.

At the same address

Other companies registered at the same address.

Directors' other companies

Other companies run by directors of this one.

Official announcements

Bankruptcy notices, liquidation notices, and other official statements about the company.

View announcements on Ametlikud Teadaanded →

Court rulings

Public court decisions where the company or its registry code is mentioned.

Search court rulings on Riigi Teataja →

General info

Shareholders

Equity holders ranked by ownership percentage.

Beneficial owners

Individuals who ultimately own or control the company.

Board (5)

Data sources

firmaotsing.ee aggregates data from Estonian public registries. Each row links to the original source.